Advertisement

Acta Endoscopica

, Volume 42, Issue 5, pp 232–236 | Cite as

Facteurs de risque et prévention du cancer gastrique

  • M. Robaszkiewicz
Vidéo-Digest
  • 180 Downloads

Risk factors and prevention of gastric carcinoma

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies. Aliment Pharmacol Ther 1999;13:851–856.PubMedCrossRefGoogle Scholar
  2. 2.
    Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology 2001;121:784–791.PubMedCrossRefGoogle Scholar
  3. 3.
    Rokkas T, Sechopoulos P, Pistiolas D, Margantinis G, Koukoulis G. Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis. Eur J Gastroenterol Hepatol 2010;22:1128–1133.PubMedCrossRefGoogle Scholar
  4. 4.
    D’Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31:489–498.PubMedCrossRefGoogle Scholar
  5. 5.
    Lunet N, Valbuena C, Vieira AL, Lopes C, Lopes C, David L, et al. Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev 2007;16:312–327.PubMedCrossRefGoogle Scholar
  6. 6.
    Lunet N, Lacerda-Vieira A, Barros H. Fruit and vegetables consumption and gastric cancer: a systematic review and meta-analysis of cohort studies. Nutr Cancer 2005;53:1–10.PubMedCrossRefGoogle Scholar
  7. 7.
    Gonzalez CA, Lujan-Barroso L, de Mesquita HB, Jenab M, Duell EJ, Agudo A, et al. Fruit and vegetable intake and the risk of gastric adenocarcinoma: a reanalysis of the european prospective investigation into cancer and nutrition (EPIC-EURGAST) study after a longer follow-up. Int J Cancer. 2012 (in press).Google Scholar
  8. 8.
    Larsson SC, Orsini N, Wolk A. Processed meat consumption and stomach cancer risk: a meta-analysis. J Natl Cancer Inst 2006;98:1078–1087.PubMedCrossRefGoogle Scholar
  9. 9.
    Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009;151:121–128. Erratum in: Ann Intern Med 2009;151:516.PubMedGoogle Scholar
  10. 10.
    Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA. 2004;291:187–194.PubMedCrossRefGoogle Scholar
  11. 11.
    Wang J, Xu L, Shi R, Huang X, Li SWH, Huang Z, Zhang G. Gastric Atrophy and Intestinal Metaplasia before and after Helicobacter pylori Eradication: a meta-analysis. Digestion 2011;83:253–260.PubMedCrossRefGoogle Scholar
  12. 12.
    Mera R, Fontham ETH, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005;54:1536–1554.PubMedCrossRefGoogle Scholar
  13. 13.
    Lee YC, Chen TH, Chiu HM, Shun CT, Chiang H, Liu TY, et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention. Gut 2012 (in press).Google Scholar
  14. 14.
    Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infection — the Maastricht IV/Florence Consensus Report. Gut 2012;61:646–664.PubMedCrossRefGoogle Scholar
  15. 15.
    Rugge M, Meggio A, Pennelli G, Piscioli F, Giacomelli L, De Pretis G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56:631–636.PubMedCrossRefGoogle Scholar
  16. 16.
    lle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc 2010;71:1150–1158.CrossRefGoogle Scholar
  17. 17.
    Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European H. Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012;44:74–94.PubMedCrossRefGoogle Scholar
  18. 18.
    Rothwell PM, Wilson M, Price JF, Belch JF, Meade TW, Mehta Z. Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials. Lancet 2012;379:1591–1601.PubMedCrossRefGoogle Scholar
  19. 19.
    Qiao YL, Dawsey SM, Kamangar F, Fan JH, Abnet CC, Sun XD. Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian general population nutrition intervention trial. J Natl Cancer Inst 2009;101:507–518.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag France 2012

Authors and Affiliations

  1. 1.Service d’hépatogastroentérologieCHU de la Cavale-BlancheBrest cedexFrance

Personalised recommendations